Posts tagged: GlaxoSmithKline
Tuesday, 9 January 2024, 7:49 am
Another day, another biopharmaucetical takeover by a major pharmaceutical company.
This time it's the turn of FTSE 100-listed GlaxoSmithKline, which is paying $1.4 billion for Aiolos Bio, Inc, a clinical-stage biopharmaceutical company developing treatments for respiratory and inflammatory conditions.
Below is the link to this morning if you would like to read all the details of the transaction:..
Read more...
Tuesday, 18 April 2023, 8:20 am
New deals are being announced on a daily basis at the moment, with the pharmaceutical sector one of the most buoyant for dealmaking.
The latest deal is GlaxoSmithKline's takeover of Canadian biopharmaceutical company Bellus Health for $14.75 a share or around £1.6 billion.
That price is double Bellus Health's closing price of $7.26!
Below is a link to the press release if you want to read all the detail of the deal:..
Read more...
Wednesday, 11 January 2023, 2:14 pm
It's that time of the year when scribblers at Canaccord Genuity's Quest release a note with their UK M&A takeover tips - all 94 of them.
Graham Simpson who compiled this list of of potential takeover targets, writes: "UK companies continue to look materially undervalued, potentially making them takeover targets for both private equity and international corporates."..
Read more...
Betaville IntelligenceTuesday, 22 March 2022, 4:24 pm
The European-based investor group seeking to persuade the board of Aurinia Pharmaceuticals to carry out a strategic review has appointed a US lawyer to manage an action group for other investors looking to back its activist campaign.
The move comes as the investment consortium, led by the Switzerland-based MKT Tactical Fund, recently wrote a second letter to the chairman of Aurinia, George Milne Junior...
Read more...
Exclusive to Betaville Intelligence subscribersMonday, 7 March 2022, 3:00 pm
Friday, 11 February 2022, 8:21 am
Has GlaxoSmithKline truly given up its pursuit of Aurinia Pharmaceuticals, the US-listed drug developer?
Last year Betaville Intelligence reported that GSK was one of the pharmaceutical giants circling Aurinia but now The Times is reporting the FTSE 100-listed group is looking at a different takeover target...
Read more...
Sunday, 23 January 2022, 12:37 pm
The Unilever might be a target for Nelson Peltz theory was first aired last summer but now it appears to be have become fact.
Indeed, hacks at the venerable Financial Times have dug a decent scoop today about Peltz building a stake after the botched £50 billion tilt GlaxoSmithKline's consumer division. Below is a link to the FT piece:..
Read more...
Saturday, 22 January 2022, 8:43 am
Dominic O'Connell, a former boss during my time jobbing on The Sunday Times busines desk, appears to be suggesting something similar to Sky News's Ian "Kingy" King earlier in the week...
Read more...
Monday, 17 January 2022, 9:57 pm
Well, it looks like Ian "Kingy" King is first out of the traps to highlight something little old Betaville had been ruminating on with an old City contact over a few glasses down the pub this evening.
In a piece today King, a former City editor of The Times and now business presenter at Sky News, argues Unilever may have accidently put itself in play after attempting to buy GlaxoSmithKline's consumer division for £50 billion. Below is the link:..
Read more...
Saturday, 15 January 2022, 9:59 am
There is a big deal story breaking this Saturday morning from, er, The Sunday Times.
Oliver "Shahsy" Shah and Sabah Meddings have dug out a jumbo scoop about FTSE 100-listed Unilever launching a £50 billion takeover bid for GlaxoSmithKline's consumer division. Below is a link to their cracking tale:..
Read more...